Omnia Family Wealth’s Ocular Therapeutix OCUL Stock Holding History

Omnia Family Wealth’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-500	Closed	-$2K	–	389
2019 Q1	$2K	Hold	500	–	–	﹤0.01%	477
2018 Q4	$2K	Hold	500	–	–	﹤0.01%	430
2018 Q3	$3K	Hold	500	–	–	﹤0.01%	382
2018 Q2	$3K	Hold	500	–	–	﹤0.01%	364
2018 Q1	$3K	Hold	500	–	–	﹤0.01%	375
2017 Q4	$2K	Hold	500	–	–	﹤0.01%	475
2017 Q3	$3K	Hold	500	–	–	﹤0.01%	395
2017 Q2	$5K	Buy	+500	New	+$4.84K	﹤0.01%	405

Other funds holding OCUL

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omnia Family Wealth's OCUL Position: Q2 2019 in Review

Omnia Family Wealth sold out of Ocular Therapeutix (OCUL) in Q2 2019, closing a stake of 500 shares — an estimated $2K sold.

Omnia Family Wealth first reported a position in OCUL in Q2 2017 and held it in 8 quarters. The position peaked at $5K in Q2 2017. 68 funds tracked by Wall St. Rank hold OCUL as of Q2 2019.

Omnia Family Wealth reported no remaining Ocular Therapeutix position as of Q2 2019 after selling out during the quarter.
Omnia Family Wealth sold 500 Ocular Therapeutix shares in Q2 2019, an estimated $2K.
Omnia Family Wealth first reported a position in Ocular Therapeutix in Q2 2017 and held it in 8 quarters.
Omnia Family Wealth's Ocular Therapeutix position peaked at $5K in Q2 2017.
68 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2019.

Based on Omnia Family Wealth's 13F filing for Q2 2019, filed 7 Aug 2019.